Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 4
Submit an article Journal homepage
162
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Severe treatment-resistant autoimmune haemolytic anaemia following ipilimumab in a patient with metastatic melanoma and CLL

Dale Jobsona Department of Dermatology, Peter MacCallum Cancer Centre, Melbourne, Australia;b University of Edinburgh, Edinburgh, United Kingdom
,
Christopher J. McCormacka Department of Dermatology, Peter MacCallum Cancer Centre, Melbourne, Australia;c Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
,
Emma Hiscutta Department of Dermatology, Peter MacCallum Cancer Centre, Melbourne, Australia
&
Constantine Tamd Haematology Department, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia;e Department of Medicine, University of Melbourne, Melbourne, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9759-5017
ORCID Icon
Pages 992-994 | Received 13 Sep 2020, Accepted 02 Nov 2020, Published online: 21 Nov 2020

References

  • Darvin P, Toor SM, Nair VS, et al. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med. 2018;50(12):1–11.
  • Villadolid J, Amin A. Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities. Transl Lung Cancer Res. 2015;4(5):560–575.
  • Abdel-Wahab N, Shah M, Suarez-Almazor ME. Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports. PloS One. 2016;11(7):e0160221.
  • Algaze SD, Park W, Harrington TJ, et al. Autoimmune haemolytic anaemia in a patient with advanced lung adenocarcinoma and chronic lymphocytic leukaemia receiving nivolumab and intravenous immunoglobulin. Case Rep. 2018;2018:bcr2017221801.
  • Nair R, Gheith S, Nair SG. Immunotherapy-associated hemolytic anemia with pure red-cell aplasia. N Engl J Med. 2016;374(11):1096–1097.
  • Simeone E, Grimaldi AM, Esposito A, et al. Serious haematological toxicity during and after ipilimumab treatment: a case series. J Med Case Rep. 2014;8(1):240.
  • Zent CS, Kay NE. Autoimmune complications in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol. 2010;23(1):47–59.
  • Hisada M, Biggar RJ, Greene MH, et al. Solid tumors after chronic lymphocytic leukemia. Blood. 2001;98(6):1979–1981.
  • Khan U, Ali F, Khurram MS, et al. Immunotherapy-associated autoimmune hemolytic anemia. J Immunother Cancer. 2017;5(1):15.
  • Schwab K, Heine A, Weimann T, et al. Development of hemolytic anemia in a nivolumab-treated patient with refractory metastatic squamous cell skin cancer and chronic lymphatic leukemia. Case Rep Oncol. 2016;9(2):373–378.
  • Tardy MP, Gastaud L, Boscagli A, et al. Autoimmune hemolytic anemia after nivolumab treatment in Hodgkin lymphoma responsive to immunosuppressive treatment. A case report. Hematol Oncol. 2017;35(4):875–877.
  • Ni D, AlZahrani F, Smylie M. AIHA and pancytopenia as complications of pembrolizumab therapy for metastatic melanoma: a case report. Case Rep Oncol. 2019;12(2):456–465.
  • Ogawa K, Ito J, Fujimoto D, et al. Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case report. Invest New Drugs. 2018;36(3):509–512.
  • Olson DJ, Rajagopal P, Tjota MY, et al. A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab. J Immunother Cancer. 2020;8(1):e000380.
  • Palla AR, Kennedy D, Mosharraf H, et al. Autoimmune hemolytic anemia as a complication of nivolumab therapy. Case Rep Oncol. 2016;9(3):691–697.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.